Global Optical Genome Mapping Market Size (2024 - 2029)

The optical genome mapping market is anticipated to experience significant growth, driven by increased government initiatives and research in genome mapping, which are enhancing the market's scope. The technology's application in understanding COVID-19 variability and its integration into whole-genome sequencing projects further underscore its importance. Additionally, strategic industry moves, such as mergers and acquisitions, are contributing to market expansion. Despite these growth drivers, the market faces challenges due to a shortage of skilled technicians necessary for complex procedures.

Market Size of Global Optical Genome Mapping Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Optical Genome Mapping Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 18.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Optical Genome Mapping Market Key Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Optical Genome Mapping Market Analysis

The optical genome mapping market is expected to register a CAGR of 18.5% over the forecast period 2022-2027.

Initially, the COVID-19 pandemic had a considerable impact on the optical genome mapping market due to the unpredicted spread. According to the article 'Host genome analysis of structural variations by Optical Genome Mapping provides clinically valuable insights into genes implicated in critical immune, viral infection, and viral replication pathways in patients with severe COVID-19' published by the medRxiv in 2021 says that to understand the inter-individual variability associated with SARS-CoV-2 infections and COVID19 mortality, optical genome mapping can be a powerful tool to recognize large Structural variations (SV) affecting clinical outcome with split survival and add valuable genomic information to the current sequencing-based technology databases.

Further, the increase in Government initiatives to research more in the genome mapping area is driving the market to grow. For example, according to the information published in Press Information Bureau, the Government of India, Ministry of Science & Technology in March 2020 sanctioned the project named 'GenomeIndia: Cataloguing the Genetic Variation in Indians'. The project is based on Whole Genome Sequencing (WGS) which is expected to be completed for 10,000 people in three years, representing the country's diverse population. The foundation for whole-genome sequencing was laid through optical genome mapping. To help with a genome assembly, sequenced DNA fragments can be aligned to the genome map. The information obtained from whole-genome sequencing can help the country's future human genetics research be more precise, as well as design a genome-wide association array for the Indian population, allowing for the development of precision healthcare and diagnostics for major diseases at a lower cost.

Furthermore, industry players are pursuing marketing strategies such as mergers and acquisitions, as well as product releases. for instance, in June 2022, Hamilton and Bionano Genomics, Inc. announced that they have collaborated on the development of the Long String VANTAGE for the isolation of Ultra High Molecular Weight (UHMW) DNA for optical genome mapping (OGM). An important prerequisite and initial stage in Bionano's sample preparation workflow is the extraction of high-quality and quantity UHMW DNA. UHMW DNA extraction is usually done by hand by highly skilled and experienced laboratory employees, limiting the amount of DNA extracted and its use in regular sample preparation. The businesses plan to engage with a few clinical research labs to test and further develop applications for the Long String VANTAGE and Bionano Prep SP kits, with some of these workflows expected to be commercialized by the end of 2022.

The investigated market is expected to grow throughout the analysis period for the reasons stated. However, the lack of skilled technicians to perform complex procedures restrain the market growth.

Optical Genome Mapping Industry Segmentation

As per the scope of the report, Optical genome mapping (OGM) is a high-resolution genome-wide examination that highlights copy number and structural anomalies, including balanced translocations, using ultra-high molecular weight DNA molecules. The optical genome mapping market is segmented by Product Type (Instruments (Optical Genome Mapping Instrument), Consumables), End Users (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Others) Geography (North America, Europe, Asia-Pacific, South America, Middle East, and Africa). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type
Instruments(Optical Genome Mapping Instrument)
Consumables
By End-User
Biotechnology & Pharmaceutical Companies
Research & Academic Institutions
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of World
Need A Different Region Or Segment?
Customize Now

Global Optical Genome Mapping Market Size Summary

The optical genome mapping market is poised for significant growth, driven by advancements in genomic research and increasing government initiatives. The technology has gained prominence for its ability to detect large structural variations in genomes, offering insights that are crucial for understanding complex diseases and conditions. The COVID-19 pandemic highlighted the utility of optical genome mapping in studying genetic variations associated with severe infections, further propelling interest in the technology. Government projects, such as India's GenomeIndia, aim to catalog genetic variations across diverse populations, leveraging optical genome mapping to enhance precision healthcare and diagnostics. Industry players are actively engaging in strategic collaborations and product developments to expand their market presence, with notable partnerships like that of Hamilton and Bionano Genomics focusing on improving DNA extraction processes for optical genome mapping.

North America currently dominates the optical genome mapping market, attributed to its robust genetic research infrastructure and the presence of key industry players. The region's growth is further supported by innovative applications of whole-genome sequencing, as seen in initiatives by the United States Food and Drug Administration to enhance food safety. The competitive landscape is characterized by strategic acquisitions and collaborations among major companies, such as Bionano Genomics and BioDiscovery, aiming to integrate optical genome mapping with other genomic data types. These developments are expected to drive the market forward, with optical genome mapping instruments anticipated to see substantial growth due to their high-resolution capabilities and cost-effective, automated processes for detecting structural variants.

Explore More

Global Optical Genome Mapping Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rapidly Increasing Bio-Pharmaceutical Advances in Drug Development Coupled with Government Funding

      2. 1.2.2 Cost-effectiveness and Accuracy

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Skilled Technicians & Complex Procedures

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product Type

      1. 2.1.1 Instruments(Optical Genome Mapping Instrument)

      2. 2.1.2 Consumables

    2. 2.2 By End-User

      1. 2.2.1 Biotechnology & Pharmaceutical Companies

      2. 2.2.2 Research & Academic Institutions

      3. 2.2.3 Others

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Rest of World

Global Optical Genome Mapping Market Size FAQs

The Global Optical Genome Mapping Market is projected to register a CAGR of 18.5% during the forecast period (2024-2029)

Bionano Genomics, OpGen, Nabsys , Nucleome Informatics Private Limited and PerkinElmer, Inc. are the major companies operating in the Global Optical Genome Mapping Market.

Optical Genome Mapping Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)